(Reuters) - The Melville, New York-based company, which also supplies vaccines and veterinary products, said first-quarter net income was $43.5 million, or 48 cents a share, compared with $16.3 million, or 18 cents a share, a year earlier.
Wall Street analysts on average had forecast 48 cents a share, according to Reuters Estimates.
Read more at Reuters.com Market News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment